Money Behind First CRISPR Test? It’s from Internet Billionaire Sean Parker
By Antonio Regalado,
MIT Technology Review
| 06. 20. 2016
The first proposed test of CRISPR gene-editing technology in human beings is being funded by Internet billionaire Sean Parker, MIT Technology Review has learned.
The novel cancer treatment, initially disclosed last week, is being reviewed Tuesday by a federal advisory panel in Washington, D.C., and could become the first clinical trial involving CRISPR, the red-hot gene modification technology.
Now we can report that Parker, a 36-year-old whose net worth is estimated at $2.4 billion, is financing the study.
Continue reading on MIT Technology Review
Image via Flickr/JD Lasica
Related Articles
By Dareh Gregorian, NBC News | 10.17.2024
By Mackenzie Mays, Los Angeles Times | 10.29.2024
SACRAMENTO — Gov. Gavin Newsom signed a bill on Sunday that requires large health insurance companies to cover in vitro fertilization — a win for reproductive health advocates amid nationwide concerns about the future of access to fertility treatments.
The bill also...
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Sara Moretto, The Varsity | 09.22.2024
It was 2020. I was wrapping up grade nine science with a solid 60 per cent, hoping that if anyone saw my failed tests in the recycling bin, it would contribute to an air of mystery about me. This reason...
.jpg){kind=link}